GMAB
USDGenmab A/S ADS
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$28.540
Haut
$29.390
Bas
$28.510
Volume
2.92M
Fondamentaux de l'Entreprise
Capitalisation Boursière
17.8B
Industrie
Biotechnologie
Pays
Denmark
Statistiques de Trading
Volume Moyen
2.00M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
More than 20 abstracts, including seven oral presentations, highlight advancements from the epcoritamab development program supporting the expanded clinical profile and potential of epcoritamab for a broader range of
HC Wainwright & Co. Reiterates Buy on Genmab, Maintains $40 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Genmab with a Buy and maintains $40 price target.
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025
Company Announcement Net sales of DARZALEX® in the third quarter of 2025 totaled USD 3,672 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech,
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.